OLMAT AMH 40 TAB

About

This medication represents a powerful triple-combination therapy specifically formulated for the comprehensive management of essential hypertension. It integrates Olmesartan, an angiotensin II receptor blocker (ARB); Amlodipine, a dihydropyridine calcium channel blocker (CCB); and Hydrochlorothiazide, a thiazide diuretic. Olmesartan works by blocking the vasoconstrictor and aldosterone-secreting effects of angiotensin II, leading to vasodilation and reduced blood pressure. Amlodipine relaxes the smooth muscles in arterial walls, causing peripheral vasodilation and further lowering blood pressure. Hydrochlorothiazide enhances the excretion of sodium and water by the kidneys, thereby reducing blood volume and contributing to antihypertensive effects. This multi-pronged approach targets distinct physiological pathways involved in blood pressure regulation, making it highly effective for patients whose hypertension is not adequately controlled by dual therapy, offering robust and sustained blood pressure control.

Uses

• Treatment of essential hypertension
• Management of severe or resistant hypertension
• When blood pressure is not controlled by dual therapy
• Reduction of cardiovascular risk associated with high blood pressure

Directions For Use

Take one tablet orally once daily, preferably at the same time each day, with or without food.

Benefits

• Potent and effective blood pressure reduction
• Targets multiple mechanisms of hypertension
• Offers comprehensive control for resistant hypertension
• Reduces the risk of heart attack and stroke
• Convenient once-daily dosing
• Improves overall cardiovascular outcomes

Side Effects

• Dizziness
• Headache
• Peripheral edema (swelling)
• Fatigue
• Nausea
• Diarrhea
• Muscle cramps
• Increased urination
• Cough (less common than ACE inhibitors)
• Hypotension (low blood pressure)
• Electrolyte imbalances (e.g., hypokalemia)
• Increased blood sugar

Safety Measures

• Alcohol - Alcohol can increase the blood pressure-lowering effect and risk of dizziness. Avoid excessive consumption.
• Pregnancy - Contraindicated in the second and third trimesters of pregnancy due to fetal toxicity (ARBs).
• Breastfeeding - Not recommended during breastfeeding as components may pass into breast milk and affect the infant.
• Liver - Use with caution in patients with mild to moderate hepatic impairment. Contraindicated in severe liver disease.
• Kidney - Contraindicated in anuria and severe renal impairment. Use with caution and monitor kidney function in other renal conditions.
• Lung - Generally safe for use in patients with lung conditions; however, hydrochlorothiazide can rarely exacerbate gout or electrolyte imbalances.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.